Work

A phase 1–2 clinical study of a second generation oral MEK inhibitor, PD 0325901 in patients with advanced cancer

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.3011

Authors: P. Lorusso, S. Krishnamurthi, J. R. Rinehart, L. Nabell, G. Croghan, M. Varterasian, S. S. Sadis, S. S. Menon, J. Leopold, M. B. Meyer

Institutions: Mayo Clinic, Wayne State University, Case Comprehensive Cancer Center

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2273990438

Cites:

Cited by: 89

Related to: 10